ライフサイエンスコーパス: compassionate

1 needing permission to self-care and be self-compassionate.

2 d from themselves to be self-caring and self-compassionate.

3 atients were evaluated for eligibility for a compassionate 5-FU/oxaliplatin protocol.

4 trials (NCT03042312, ACTRN12615000912583) or compassionate access programmes at six hospitals and aca

5 Despite over one-hundred Canadians receiving compassionate access since 2020, there has been little e

6 n who were treated with (177)Lu-PSMA under a compassionate-access program at our institution and had

7 Although examples of compassionate and attentive care can be found in every s

8 accomplished in an environment dedicated to compassionate and ethical care.

9 Compassionate and honest communication about prognosis a

10 ategy can make hospice discussions both more compassionate and more effective.

11 ical safety and activity data collection for compassionate and off-label new anticancer medicines.

12 ery 8 weeks to individuals with HAM/TSP as a compassionate and palliative treatment.

13 lly supports the intuitive expectations that compassionate and respectful care for the deceased and f

14 on, and effective communication and provided compassionate and respectful patient care.

15 care to match these trajectories, as well as compassionate and skillful clinicians.

16 itate interventions to improve high-quality, compassionate, and culturally sensitive decision-making

17 on to provide settings that offer dignified, compassionate, and skilled care.

18 notifying families of a patient's death and compassionate approaches to discussing options for organ

19 ine the goals of universal screening so that compassionate asking in and of itself constitutes the fi

20 Treatment was administered on a compassionate basis (open-label).

21 treated with HSCT as part of a study or on a compassionate basis at Northwestern University (Chicago,

22 e 22-46) years were treated with phages on a compassionate basis because their clinical course was co

23 2Ar patients treated with this approach on a compassionate basis had an overall response rate of 90%.

24 oroquine (200mg tid dosage for 10 days) on a compassionate basis in addition to SOCwere compared to p

25 00 mg 3 times daily dosage for 10 days) on a compassionate basis in addition to standard of care (SOC

26 aematopoietic stem cell transplantation on a compassionate basis in four European centres.

27 hereas Bevacizumab was reserved for use on a compassionate basis in patients not meeting treatment cr

28 available for use only on a "named patient" compassionate basis in the United Kingdom.

29 gle centre studies and the use of drugs on a compassionate basis should be replaced by highly powered

30 Voriconazole was prescribed on a compassionate basis to patients with IFI who were intole

31 endocardium (SESAME) to treat patients, on a compassionate basis, with symptomatic LVOT obstruction o

32 e Care Programme, LCCP) seeking to integrate compassionate care across practice and educational envir

33 taff are not likely to significantly improve compassionate care alone in the context of extremely cha

34 three patients with lymphoma or leukemia for compassionate care and observed no clinical signs of gra

35 With hard work, perseverance, excellence,compassionate care and support and mentoring, many have

36 However, compassionate care can be hindered when working in very

37 studies, clinical trials, and emergency-use compassionate care cases has centered around the origina

38 most efficient way to deliver effective and compassionate care for all.

39 lity to do this affected their wellbeing and compassionate care giving to others.

40 d self-compassion and how this may relate to compassionate care giving towards patients.

41 s care for themselves as they try to provide compassionate care in a challenging job.

42 , including a value system that supports the compassionate care of patients, is a means of encapsulat

43 of a three year programme (the Leadership in Compassionate Care Programme, LCCP) seeking to integrate

44 PSMA-617 (AcPSMA), which were acquired under compassionate care regulations in patients with advanced

45 r biventricular repair, leading to unplanned compassionate care, additional surgery or increase of th

46 ningful factors emerged (perspective taking, compassionate care, and standing in the patient's shoes)

47 he 84 centers for clinical standard of care, compassionate care, or local research protocols and 11 (

48 ity of patients or increases the delivery of compassionate care.

49 and therapy in 3 prostate cancer patients in compassionate care.

50 ivered, rather than as a means of increasing compassionate care.

51 f potential conflict and continue to provide compassionate care.

52 se principles, however, are insufficient for compassionate care.

53 physician relationship, including attention; compassionate care; and the modulation of expectations,

54 roved via the IND (investigational new drug) compassionate-care route.

55 Compassionate caring and promoting dignity are key prior

56 eatments were administered to patients under compassionate circumstances with promising results, and

57 legacies of their loved ones while inspiring compassionate clinical care.

58 mong studies, or obviate the need for sound, compassionate clinical reasoning.

59 71 +/- 9 years, 2 men) who had TMVR under a compassionate clinical use program.

60 e targeted self-compassion via creation of a compassionate coach (CC) image.

61 Compassionate collection involves minimizing harm while

62 rspective that advocated for the adoption of compassionate collection practices, querying whether it

63 palliative care emerged: timely, clear, and compassionate communication by clinicians; clinical deci

64 milies include the following key components: compassionate communication; exploration of patient and

65 munity-based supports through development of compassionate communities and upskilling of professional

66 measured globally and through its positive (compassionate concern) and negative (callousness) dimens

67 ach to help clinicians provide effective and compassionate decision support to patients with advanced

68 Nearly all participants described compassionate disclosure of test results by ED/UC provid

69 entional practices to preserve personalized, compassionate end-of-life care for dying hospitalized pa

70 findings suggest that to increase access to compassionate evidence-based treatment for OUD, clinicia

71 Levels of compassionate fatigue in nurses increased gradually from

72 We treated 90 iTTP patients with a compassionate frontline triplet regimen associating ther

73 Review of the literature shows that compassionate health care measurably improves physical a

74 person to hold these conversations should be compassionate, helpful, and knowledgeable of the patient

75 y alike urge professionals to be empathetic, compassionate, honest, and caring.

76 tive beliefs about the self and others using compassionate imagery causes reductions in paranoia.

77 Compassionate imagery may be one way of reducing such ne

78 compassionate) individuals but stronger in those who wer

79 kage activities should be trained to deliver compassionate, informed, and thoughtful care that bridge

80 for cholera control will require a new, more compassionate, less risk-averse generation of decision m

81 to be proactively more self-caring and self-compassionate may increase their ability to manage emoti

82 he results point to a need for well-crafted, compassionate messaging that reaches out to those most r

83 h actively train distress tolerance, such as Compassionate Mind Training (CMT), are less well known.

84 tion-by-death" mean that our society is more compassionate now, or more just, than in the past?

85 on effectiveness of interventions to support compassionate nursing care has been reported, no rigorou

86 If an intervention to increase compassionate nursing care is required, it may be better

87 al rounding neither improves the delivery of compassionate nursing care nor addresses the policy impe

88 mparing outcomes of interventions to promote compassionate nursing care with a control condition were

89 ath to corporate success is unlikely to be a compassionate one.

90 only responsible approach from a scientific, compassionate, or economic view (and why not combine all

91 transplanted between 11/93-5/94 and received compassionate oral tacrolimus induction.

92 s the physician to provide comprehensive and compassionate palliative care at the end of life.

93 ties, it is possible and appropriate to give compassionate palliative care to dying patients and thei

94 hat will provide competent, coordinated, and compassionate patient- and family-centered care?

95 The astute, compassionate pediatric surgeon does much to enhance the

96 IV allopurinol was provided on a compassionate plea basis to patients of any age in whom

97 additional babies received ganciclovir on a compassionate plea basis.

98 ble and timely information, better training, compassionate recognition of their anxiety, guidance in

99 ff and relatives in agreeing a definition of compassionate relationship-centred care and identifying

100 dds considerably to the conceptualization of compassionate, relationship-centred care and provides a

101 'appreciative caring conversations' promotes compassionate, relationship-centred care but that these

102 equally challenging demands of establishing compassionate relationships with family members and comm

103 olicy experts are calling for broader use of compassionate release because of many factors, such as a

104 Compassionate release derives from the theory that chang

105 Compassionate release is a program that allows some elig

106 ss because eligibility for consideration for compassionate release is generally based on medical evid

107 Compassionate release policies can address this gap by a

108 Forty-five patients were enrolled in a compassionate release program (29 [64%] because of failu

109 patient would be arriving from prison under compassionate release.

110 re access for aging individuals eligible for compassionate release.

111 so, the medical eligibility criteria of many compassionate-release guidelines--which often assume a d

112 Adjustment for compassionate releases eliminated the protective effect

113 to occur in the context of incarceration and compassionate releases of moribund patients.

114 motivated governments, dedicated funds, and compassionate scientific partnership.

115 ost prominent reasons for diversion were (1) compassionate sharing with intimate partners and friends

116 an as warmer and more caring, sensitive, and compassionate than did women who watched the "standard"

117 On the basis of compassionate treatment data, posaconazole appears to be

118 te models and have been used under emergency compassionate-treatment protocols in human patients.

119 Clinical trials and compassionate use agreements provide selected patients w

120 tial clinical trials are expected to explore compassionate use as destination therapy in carefully se

121 Other centers were approved on a compassionate use basis after contacting the primary inv

122 aerosolization, or both to 20 patients on a compassionate use basis and patients were monitored for

123 n human decedents and living recipients on a compassionate use basis have provided impetus to advanci

124 ng transplant candidates and recipients on a compassionate use basis targeting mostly MDR gram-negati

125 to-human heart transplant was performed on a compassionate use basis, and xenotransplantation experim

126 ocetaxel) was treated with lenalidomide on a compassionate use basis.

127 h MDR tuberculosis receiving bedaquiline for compassionate use between January 2010 and July 2013 and

128 treatment of ten patients with CFZ under the compassionate use CarCAR protocol - after relapse follow

129 Clinical outcomes from initial studies and compassionate use cases are discussed, highlighting the

130 mitral regurgitation in the patients in this compassionate use cohort, technical success was achieved

131 early feasibility study or on the basis of a compassionate use exemption.

132 a phase 1 trial and has been provided under compassionate use for both HeV and NiV exposures.

133 Moreover, KPT-330 compassionate use in a patient with TKI-resistant CML un

134 options within experimental protocols or as compassionate use in small patient groups.

135 We previously reported compassionate use of an adeno-associated virus (AAV) vec

136 A protocol for the compassionate use of CPDG2 in patients who develop nephr

137 ctor in STEC-HUS pathophysiology, leading to compassionate use of eculizumab, a monoclonal antibody i

138 cal cannabinoid inhaler; and recommends that compassionate use of marijuana be considered under caref

139 In the Compassionate Use of Protease Inhibitors in Viral C Cirr

140 We describe successful compassionate use of recombinant human interleukin 7 in

141 le to pregnant women with severe COVID-19 to compassionate use of remdesivir, or off-label drug use o

142 We report on the successful, compassionate use of the anti-CD20 chimeric monoclonal a

143 he experimental treatment (p < .01); or seek compassionate use of the experimental treatment (p < .01

144 Compassionate use of this regimen was initiated for the

145 r, a single case report was presented on the compassionate use of tin mesoporphyrin in a very low bir

146 Here we examined compassionate use of tocilizumab in patients with SARS-C

147 eoplasms) or related conditions who received compassionate use or off-label innovative anticancer the

148 using this investigational device under the compassionate use pathway.

149 uren in three patients with SDS undergoing a compassionate use program for twelve months.

150 A001, J9950, and J0443 trials and the French compassionate use program).

151 [51%]) were prescribed these drugs within a compassionate use program, mainly as single agents (74%)

152 clinicians requested remdesivir through the compassionate use program.

153 leoside to 16 TK2-deficient patients under a compassionate use program.

154 clinicians requested remdesivir through the compassionate use program.

155 care hospitals in five countries that had a compassionate use programme in which patients underwent

156 t is associated with treatment allocation in compassionate use programs (i.e., observational studies)

157 ide their marketing authorization or through compassionate use programs.

158 as part of single-arm, open-label studies or compassionate use programs.

159 rtum women with severe COVID-19 who received compassionate use remdesivir, recovery rates were high,

160 received prior SBRT as part of an 11-patient compassionate use series at our institution.

161 Two consecutive compassionate use studies of oxaliplatin were conducted

162 -blinded, randomized, bilaterally controlled compassionate use study of topical gentamicin in which f

163 Intra-articular injection in a clinical compassionate use study showed that the treatment restor

164 infection, was administered as an open label compassionate use therapeutic for COVID-19.

165 osure interventions have been employed under compassionate use to treat patients repatriated to Europ

166 It has been administered under compassionate use to two Ebola patients, both of whom su

167 Approval for expanded access and compassionate use was rapidly sought and obtained from r

168 sing of available drugs for personalized and compassionate use, and even the development of new drug

169 Under compassionate use, chimeric antigen receptor (CAR) T cel

170 ials or treated with radretumab according to compassionate use, describing the biodistribution, dosim

171 t patients granted REGEN-COV under emergency compassionate use, REGEN-COV treatment was associated wi

172 In the setting of compassionate use, the evidence of phage-induced lysis w

173 and imdevimab (REGEN-COV(R)) under emergency compassionate use.

174 A) with the CD19xCD3 BiTE blinatumomab under compassionate use.

175 bacteriophage treatment for 12 months under compassionate use.

176 traClip treatment for chronic, severe TR for compassionate use.

177 ed in non-randomised studies on the basis of compassionate use.

178 Adults with compassionate-use access arrangements were also eligible

179 s well as to 2 adults who were treated under compassionate-use access arrangements.

180 Compassionate-use approval for the procedure was obtaine

181 ed sofosbuvir (SOF) and ribavirin (RBV) on a compassionate-use basis to patients with severe recurren

182 of this trial was to provide sunitinib on a compassionate-use basis to trial-ineligible patients wit

183 administered by portable infusion pump on a compassionate-use basis.

184 vere VOD after SCT were treated with DF on a compassionate-use basis.

185 atment was offered to patients with EVD on a compassionate-use basis.

186 ppressive drug treatments were enrolled in a compassionate-use chimeric antigen receptor (CAR) T cell

187 -CD20 therapies are desirable.OBSERVATIONS A compassionate-use investigational new drug protocol was

188 efore glass microspheres can be used under a compassionate-use or research protocol.

189 In a compassionate-use pilot study, two patients with severe

190 available to US gastroenterologists under a compassionate-use program by Janssen Pharmaceutica, as t

191 nfected patients participating in an Italian compassionate-use program of ombitasvir/paritaprevir/rit

192 rolymphocytic leukemia (T-PLL) patients in a compassionate-use program.

193 chemical evidence of MoCD were admitted to a compassionate-use programme at the request of their trea

194 e (KPC-Kp) in adults who received CAZ-AVI in compassionate-use programs in Italy.

195 tients were treated with ZMapp or ZMAb under compassionate-use protocols.

196 rtum women with severe COVID-19 who received compassionate-use remdesivir, recovery rates were high,

197 treating bacterial infections, encompassing compassionate-use scenarios and clinical trials.

198 rong pathogen-specific T-cell expansion in a compassionate-use setting.

199 infection, was administered as an open-label compassionate-use therapeutic for coronavirus disease 20

200 Furthermore, compassionate-use treatment of a single patient with aty

201 tumomab tiuxetan regimen in registration and compassionate-use trials between 1996 and 2002.

202 is of data from patients in registration and compassionate-use trials suggests that the annualized in

203 erment, and career commitment (as proxies of compassionate values and behaviours), and focus groups.

204 h positive and negative effects on students' compassionate values and behaviours, however positive ef

205 ive intervention to foster nursing students' compassionate values and behaviours.

206 tient perception of physicians as being less compassionate when they deliver bad news might be a cont

207 Taking felt more positive (e.g., connected, compassionate), whereas those with higher Personal Distr

208 in enabling nurses to self-care and be self-compassionate, which may facilitate them to address pati

209 Recent human decedent model studies(1,2) and compassionate xenograft use(3) have explored the promise